Flow‐mediated vasodilatation: variation and interrelationships with plasma lipids and lipoproteins

References

• Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., et al. Non‐invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111–15
   PubMed Web of Science ®Google Scholar
• Neunteufl T., Katzenschlager R., Hassan A., Klaar U., Schwarzacher S., Glogar D., et al. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease. Atherosclerosis 1997; 129: 111–18
   PubMed Web of Science ®Google Scholar
• Sanderson P., Sattar N., Olthof M., Grimble R. F., Calder P. C., Griffin B. A., et al. Dietary lipids and vascular function: UK Food Standards Agency workshop report. Br J Nutr 2004; 91: 491–500
   PubMed Web of Science ®Google Scholar
• Griffin B. A. Lipoprotein atherogenicity: an overview of current mechanisms. Proc Nutr Soc 1999; 58: 163–9
   PubMed Web of Science ®Google Scholar
• Nordestgaard B. G., Zilversmit D. B. Comparison of arterial intimal clearances of LDL from diabetic and nondiabetic cholesterol‐fed rabbits. Differences in intimal clearance explained by size differences. Arteriosclerosis 1989; 9: 176–83
   PubMedGoogle Scholar
• de G. J., Hak‐Lemmers H. L., Hectors M. P., Demacker P. N., Hendriks J. C., Stalenhoef A. F. Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991; 11: 298–306
   PubMedGoogle Scholar
• Anber V., Griffin B. A., McConnell M., Packard C. J., Shepherd J. Influence of plasma lipid and LDL‐subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996; 124: 261–71
   PubMedGoogle Scholar
• Marcel Y. L., Vezina C., Teng B., Sniderman A. Transfer of cholesterol esters between human high density lipoproteins and triglyceride‐rich lipoproteins controlled by a plasma protein factor. Atherosclerosis 1980; 35: 127–33
   PubMedGoogle Scholar
• Sniderman A., Thomas D., Marpole D., Teng B. Low density lipoprotein. A metabolic pathway for return of cholesterol to the splanchnic bed. J Clin Invest 1978; 61: 867–73
   PubMed Web of Science ®Google Scholar
• Lagrost L., Barter P. J. Effects of various non‐esterified fatty acids on the transfer of cholesteryl esters from HDL to LDL induced by the cholesteryl ester transfer protein. Biochim Biophys Acta 1991; 1085: 209–16
   PubMedGoogle Scholar
• Skyrme‐Jones R. A., O'Brien R. C., Luo M., Meredith I. T. Endothelial vasodilator function is related to low‐density lipoprotein particle size and low‐density lipoprotein vitamin E content in type 1 diabetes. J Am Coll Cardiol 2000; 35: 292–9
   PubMedGoogle Scholar
• Wakatsuki A., Ikenoue N., Shinohara K., Watanabe K., Fukaya T. Small low‐density lipoprotein particles and endothelium‐dependent vasodilation in postmenopausal women. Atherosclerosis 2004; 177: 329–36
   PubMed Web of Science ®Google Scholar
• Lupattelli G., Lombardini R., Schillaci G., Ciuffetti G., Marchesi S., Siepi D., et al. Flow‐mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles. Am Heart J 2000; 140: 521–6
   PubMed Web of Science ®Google Scholar
• Lewis T. V., Dart A. M., Chin‐Dusting J. P. Endothelium‐dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol. J Am Coll Cardiol 1999; 33: 805–12
   PubMed Web of Science ®Google Scholar
• Kusterer K., Pohl T., Fortmeyer H. P., Marz W., Scharnagl H., Oldenburg A., et al. Chronic selective hypertriglyceridemia impairs endothelium‐dependent vasodilatation in rats. Cardiovasc Res 1999; 42: 783–93
   PubMedGoogle Scholar
• Lamarche B., Moorjani S., Lupien P. J., Cantin B., Bernard P. M., Dagenais G. R., et al. Apolipoprotein A‐I and B levels and the risk of ischemic heart disease during a five‐year follow‐up of men in the Quebec cardiovascular study. Circulation 1996; 94: 273–8
   PubMed Web of Science ®Google Scholar
• Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G. R., Lupien P. J., et al. Small, dense low‐density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 1997; 95: 69–75
   PubMed Web of Science ®Google Scholar
• Capell W. H., DeSouza C. A., Poirier P., Bell M. L., Stauffer B. L., Weil K. M., et al. Short‐term triglyceride lowering with fenofibrate improves vasodilator function in subjects with hypertriglyceridemia. Arterioscler Thromb Vasc Biol 2003; 23: 307–13
   PubMed Web of Science ®Google Scholar
• Dupuis J., Tardif J. C., Cernacek P., Theroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation 1999; 99: 3227–33
   PubMed Web of Science ®Google Scholar
• Wang T. D., Chen W. J., Lin J. W., Cheng C. C., Chen M. F., Lee Y. T. Efficacy of fenofibrate and simvastatin on endothelial function and inflammatory markers in patients with combined hyperlipidemia: relations with baseline lipid profiles. Atherosclerosis 2003; 170: 315–23
   PubMed Web of Science ®Google Scholar
• Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502
   PubMed Web of Science ®Google Scholar
• Davies I. G., Graham J. M., Griffin B. A. Rapid separation of LDL subclasses by iodixanol gradient ultracentrifugation. Clin Chem 2003; 49: 1865–72
   PubMed Web of Science ®Google Scholar
• Lundman P., Eriksson M., Schenck‐Gustafsson K., Karpe F., Tornvall P. Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease. Circulation 1997; 96: 3266–8
   PubMed Web of Science ®Google Scholar